BIOVAXYS, COMPLETES

BioVaxys Technology Corp. Canada New York United States of America British Columbia

07.08.2025 - 18:06:03

BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS PLATFORM TECHNOLOGY, AND CLINICAL STAGE ASSETS OF THE FORMER IMV INC.

View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-completes-the-acquisition-of-all-intellectual-property-immunotherapeutics-platform-technology-and-clinical-stage-assets-of-the-former-imv-inc-302067848.html

@ prnewswire.co.uk